Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29765225 | 1.00 | GSTP1 (0.52) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL2329037 | 1.00 | GSTP1 (0.52) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL29595492 | 1.00 | GSTP1 (0.52) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL2789566 | 0.89 | GSTP1 (0.52) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL3792915 | 0.88 | GSTP1 (0.55) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL3687907 | 0.88 | GSTP1 (0.55) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL3193310 | 0.88 | GSTP1 (0.64) | GSTP1CYP1A2ALDH1A1HSD17B10HSD17B1 | |
| SCHEMBL16800914 | 0.86 | GSTP1 (0.46) | GSTP1CYP1A2FYNAHRALDH1A1 | |
| SCHEMBL1155157 | 0.86 | GSTP1 (0.46) | GSTP1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL3176171 | 0.86 | GSTP1 (0.61) | GSTP1CYP1A2ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3147962-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | NOVALED GMBH (DE) | 2021-04-21 | — | — | EP | claimed |
| EP-3147962-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Novaled GmbH (DE) | 2017-03-29 | — | — | EP | claimed |
| EP-3147961-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Novaled GmbH (DE) | 2017-03-29 | — | — | EP | claimed |
| EP-3252841-B1 | ORGANIC LIGHT EMITTING DIODE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-12563963-B2 | Electron injection layer for an organic light-emitting diode (OLED) | NOVALED GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| US-12161044-B2 | Electron transport layer comprising a matrix compound mixture for an organic light-emitting diode (OLED) | NOVALED GMBH (DE) | 2024-12-03 | — | — | US | disclosed |
| EP-3524662-B1 | LUBRICANT COMPOSITION, COMPOSITION FOR REFRIGERATING MACHINES, AND METHOD FOR DETECTING LEAKAGE POINT | IDEMITSU KOSAN CO (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-11594687-B2 | Organic electroluminescent device | NOVALED GMBH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11462588-B2 | Organic light emitting display device having sub pixels of different areas and distances | LG DISPLAY CO., LTD. (KR) | 2022-10-04 | — | — | US | disclosed |
| US-11322687-B2 | Charge transporting semi-conducting material and semi-conducting device | NOVALED GMBH (DE) | 2022-05-03 | — | — | US | disclosed |
| US-20220112996-A1 | JEWELRY AND GEM STONE LIGHTING SYSTEMS AND APPARATUSES AND METHOD MAKING AND USING SAME | ASHLEY PAUL (US) | 2022-04-14 | — | — | US | disclosed |
| US-9062368-B2 | Method of monitoring photoactive organic molecules in-situ during gas-phase deposition of the photoactive organic molecules | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-06-23 | — | — | US | disclosed |
| US-8795855-B2 | OLEDs having high efficiency and excellent lifetime | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-08-05 | — | — | US | disclosed |
| US-20140151676-A1 | OLEDS HAVING HIGH EFFICIENCY AND EXCELLENT LIFETIME | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-06-05 | — | — | US | disclosed |
| WO-2014037512-A2 | CHARGE TRANSPORTING SEMI-CONDUCTING MATERIAL AND SEMI-CONDUCTING DEVICE | NOVALED AG (DE) | 2014-03-13 | — | — | WO | disclosed |
| EP-2706584-A1 | Charge transporting semi-conducting material and semi-conducting device | Novaled AG (DE) | 2014-03-12 | — | — | EP | disclosed |
| EP-2109898-B1 | OLEDS HAVING HIGH EFFICIENCY AND EXCELLENT LIFETIME | GLOBAL OLED TECHNOLOGY LLC (US) | 2011-08-17 | — | — | EP | disclosed |
| EP-2109898-A1 | OLEDS HAVING HIGH EFFICIENCY AND EXCELLENT LIFETIME | EASTMAN KODAK COMPANY (US) | 2009-10-21 | — | — | EP | disclosed |
| WO-2008094399-A1 | OLEDS HAVING HIGH EFFICIENCY AND EXCELLENT LIFETIME | EASTMAN KODAK COMPANY (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20080182129-A1 | OLEDS HAVING HIGH EFFICIENCY AND EXCELLENT LIFETIME | GLOBAL OLED TECHNOLOGY LLC | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12563963-B2 | Electron injection layer for an organic light-emitting diode (OLED) | ICOSLG, OXA1L, OSBP2 | GSTP1 1980/4885CYP1A2 1366/4885ERBB2 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.